ϩ channels are key regulators of cellular excitability. Mutations that activate K ϩ channels can lower cellular excitability, whereas those that inhibit K ϩ channels may increase excitability. We show that the Caenorhabditis elegans egl-2 gene encodes an eag K ϩ channel and that a gain-of-function mutation in egl-2 blocks excitation in neurons and muscles by causing the channel to open at inappropriately negative voltages. Tricyclic antidepressants reverse egl-2(gf) mutant phenotypes, suggesting that EGL-2 is a tricyclic target. We verified this by showing that EGL-2 currents are inhibited by imipramine. Similar inhibition is observed with the mouse homolog MEAG, suggesting that inhibition of EAG-like channels may mediate some clinical side effects of this class of antidepressants.
K
ϩ channels are key regulators of membrane excitability and are responsible for a number of identified channelopathies underlying neurological and cardiac disorders (Adelman et al., 1995; Curran et al., 1995; Vetter et al., 1996; Wang et al., 1996) . In addition, some clinically used drugs may act via K ϩ channel blockade (Sanguinetti and Jurkiewicz, 1990) . Caenorhabditis elegans contains a f ull complement of K ϩ channel gene families (Wei et al., 1996) , and a number of K ϩ channel mutants have been identified (Elkes et al., 1997; Johnstone et al., 1997; our unpublished data) . Behavioral and pharmacological studies of these mutants may provide insight into the genetic and mechanistic basis of K ϩ channel dysf unction in vivo.
Here we report that the behavioral defects in the C. elegans egl-2 mutant are caused by a gain-of-f unction ( gf) mutation in an eag-like K ϩ channel. eag K ϩ channels are encoded by one of three distinct subfamilies of genes (eag, erg, and elk), which comprise the ether-a-go-go (EAG) extended gene family (Warmke and Ganetzky, 1994; Ganetzky et al., 1999) . Members of the EAG family of K ϩ channels generally produce noninactivating, voltage-dependent potassium currents, characterized by accentuated modulation by internal (Bruggemann et al., 1993; Stansfeld et al., 1996) and external (Terlau et al., 1996; Schonherr et al., 1999 ) divalent cations. Amino acid residues critical for controlling channel activity are largely undefined, and in vivo mutant phenotypes have previously been described only for Drosophila (Kaplan and Trout, 1969; Warmke et al., 1991) .
Imipramine and other structurally related tricyclic antidepressants reverse egl-2(gf) mutant phenotypes, but not those caused by gf mutations in other C. elegans potassium channel genes (Trent et al., 1983; Reiner et al., 1995; Weinshenker et al., 1995;  our unpublished data), suggesting a specific interaction between tricyclics and EGL-2 channels. Tricyclic drugs are used to treat depression and other affective disorders, however their potential use is limited by many clinical side effects such as cardiac arrhythmia, weight fluctuation, constipation, and sexual dysfunction (Baldessarini, 1989; Kaplan et al., 1994) . Tricyclics are thought to exert their therapeutic effect through chronic blockade of presynaptic serotonin and/or norepinephrine transporters (Frazer, 1997) , but the molecular mechanisms mediating many of the deleterious side effects have not been identified. Previous studies have reported that some native K ϩ currents can be blocked by tricyclics (Wooltorton and Mathie, 1993; Valenzuela et al., 1994; Kuo, 1998) , but the molecular identities of these channels are unknown.
To investigate the mechanism of the egl-2(gf) phenotype and rescue by imipramine, we analyzed EGL-2 currents in Xenopus oocytes. Mutant EGL-2( gf) channels exhibited a negative shift in voltage dependence of activation, and both wild-type (WT) and mutant currents were blocked by imipramine. We hypothesize that EGL-2( gf) channels cause behavioral defects through suppression of excitability in critical cells. Consistent with this possibility, EGL-2::green fluorescent protein (GFP) fusions revealed egl-2 expression in a subset of neurons and muscles that could explain the mutant behavioral defects. Suppression of egl-2(gf) phenotypes by imipramine likely results from the block of EGL-2( gf) channels. We suggest that a similar block of vertebrate EAG-like potassium channels may mediate some of the clinical side effects of tricyclic antidepressants.
MATERIALS AND METHODS
Behavioral assays. Chemotaxis assays were performed as described, with slight modifications (Bargmann et al., 1993) . Eighteen-to 22-hr-old chemotaxis plates were allowed to dry coverless for 60 min before the assay, and 1 l of 200 mM sodium azide was placed at the attractant and control spots to anesthetize the animals when they reached these spots. A minimum of three trials (at least 50 animals each) were performed for each genotype and attractant concentration. For the imipramine experiments, animals were grown on plates containing 0.7 ml of 2.4 mM imipramine (Sigma, St. L ouis, MO) and assayed on chemotaxis plates (Bargmann et al., 1993) containing 315 M imipramine. Statistical analysis was done using the unpaired Student's t test (Instat 2.01 for Macintosh).
Defecation assays were performed as described . For each genotype, a minimum of 40 defecation cycles from at least three animals were assayed. Drug experiments were performed on plates containing 0.7 ml of 2.4 mM imipramine.
Anterior Mec assays were performed essentially as described (Chalfie and Sulston, 1981) . Adult animals were picked individually to plates and assayed 45 min later. Each animal was tested for responsiveness to a light touch just posterior to the pharynx with an eyelash five times. For each genotype, at least 10 animals were touched five times each (one touch every 10 min). Imipramine experiments were performed on plates containing 0.7 ml of 2.4 mM imipramine.
Mutagenesis and mapping of egl-2(gf) revertants. Revertants of egl-2( gf ) were isolated by mutagenizing egl-2(n693sd) and egl-2(n2656sd) with ethylmethanesulfonate (EMS) as described (Brenner, 1974) and screening for non-egg laying-defective (Egl) non-expulsion-defective (E xp) animals in the F2 generation. Transposon alleles of egl-2(n693sd) were similarly isolated by screening for revertants of egl-2(n693sd) in a mut-6 mutator background. We isolated 30 EMS-induced alleles from 110,000 mutagenized genomes and three transposon insertion alleles from 90,000 mutagenized genomes. Four EMS-induced revertants of egl-2(n693sd), n904, n905, n906, and n907, were kindly provided by C. Trent and H. R. Horvitz.
lon-2(e678) males were mated to revertant hermaphrodites, and F1 progeny were picked individually to plates and allowed to self-fertilize. F1 cross progeny were non-Egl non-E xp, indicating that the revertant alleles are cis-dominant. Broods containing lon-2 mutants were screened for egl-2( gf ) animals to assess linkage between egl-2 and the suppressor. Approximately 1000 F2 progeny were screened for each revertant, and no egl-2( gf ) animals were seen, indicating that all of the suppressors are tightly linked to egl-2.
egl-2 cloning. egl-2(n693sd) was mapped between unc-34 and unc-60 on the left arm of chromosome V (Trent et al., 1983 ; data not shown). Cosmids from the region (5 ng /l) were coinjected with rol-6(d) marker DNA (200 ng /l) into egl-2(n905) animals, and transgenic lines were established as described (Mello et al., 1991). egl-2(n693sd)/egl-2(n905) heterozygotes carrying the cosmid transgene were constructed, and partial suppression of the egl-2(n693sd) expulsion-defective (E xp) phenotype was obtained with cosmids Z K1005 and Z K1012. Overlapping regions from these cosmids were used to probe Southern blots of DNA from multiple egl-2 alleles, and polymorphisms were identified in a 1.6 kb XbaI fragment in the egl-2 alleles sa373, sa400, and sa408. This fragment was subcloned and sequenced, and the sequence was used to design primers for RT-PCR. Stratagene (La Jolla, CA) 5Ј and 3Ј rapid amplification of cDNA ends kits were used to obtain overlapping partial cDNAs, which were sequenced. egl-2 genomic sequence was subsequently confirmed by the C. elegans Genome Sequencing Consortium (Coulson, 1996) . Oligonucleotides for PCR and sequencing were from Life Technologies (Gaithersburg, MD). PCR was performed on a P TC -200 DNA engine from MJ Research. Sequencing was performed on an ABI PRISM dye terminator cycle sequencer by the Biochemistry Sequencing facility and the Pharmacology Sequencing facility at the University of Washington. For mutant egl-2 alleles, PCR products from the egl-2 gene using mutant and wild-type genomic DNA as template were gel-purified and sequenced. The egl-2 cDNA GenBank accession number is AF130443.
Xenopus ooc yte e xpression and electrophysiolog y. Three overlapping partial cDNAs were constructed by RT-PCR and cloned together into the pMX T oocyte expression vector (Wei et al., 1994) . A silent mutation was introduced at base 2412 to create a SpeI site used in cloning. A f ull-length mouse ether-a-go-go (meag) clone (kindly provided by Barry Ganetzky) was cloned into the pMX T oocyte expression vector. The A478V mutation was introduced into the egl-2 cDNA by overlap PCR mutagenesis (Horton et al., 1989) . The cDNA was cloned into pMX T and sequenced to confirm the change and rule out extraneous mutations. The A492V mutation in meag was similarly generated.
C apped cRNAs were generated by in vitro transcription using a commercial T3 RNA polymerase kit (mMessagemMachine; Ambion, Austin, TX) and linearized plasmid DNA templates. Oocyte isolation, injection, and handling followed standard procedures (Soreq and Seidman, 1992; Wei et al., 1994) . Oocytes were injected with ϳ50 ng (wild-type and mutant egl-2) or 10 ng (wild-type and mutant meag) cRNA. Wild-type and mutant EGL -2 currents were obtained in choline 96 (in mM: 96 choline C l, 2 KC l, 1.8 C aC l 2 , 1.0 MgC l 2 , and 5 H EPES, pH 7.5) supplemented with 1.0 mM 4,4Ј-diisothiocyanato-stilbene-2,2Ј-disulfonic acid (Sigma) to block endogenous calcium-activated chloride currents (Barish, 1983) after 5-7 d of incubation at 19°C. Wild-type and mutant meag currents were obtained in N D96 (in mM: 96 NaCl, 2 KCl, 1.8 CaCl 2 , 1.0 MgC l 2 , and 5 H EPES, pH 7.5) after 1-3 d incubation at 19°C. Current recordings were digitally acquired by two-electrode voltage clamp with a Dagan TEV-200 amplifier and pC lamp 7 (Axon Instruments, Foster C ity, CA). Current injection and voltage electrodes had resistances between 0.5 and 1.0 M⍀ filled with 3 M KC l. Imipramine (Sigma) solutions were made in either choline 96 (wild-type and mutant EGL -2) or N D96 (wild-type and mutant M EAG) and exchanged with the bath solution by gravity flow. Data analysis was performed with Sigmaplot 4.0 (Jandel Scientific, Corte Madera, CA) and Origin 4.0 (Microcal).
GFP e xpression. For the short f usion, a PCR product containing 4.1 kb of upstream sequence, the first exon and intron, and part of the second intron of egl-2 was inserted in frame into the pPD95.75 GFP expression vector (kindly provided by A. Fire, J. Ahnn, G. Seydoux, and S. Xu). For the f ull-length f usion, an NheI fragment from cosmid Z K1005 containing 5 kb upstream of egl-2, the entire egl-2 coding region (10 kb), and 4.2 kb downstream of egl-2 was cloned into the XbaI site of Bluescript (Stratagene). The GFP coding region was generated by PCR from pPD95.75 and cloned in frame into the AgeI site in exon 13 of egl-2 in the plasmid described above. The stop codon in GFP was mutated to a leucine codon so that the egl-2 gene would be translated in its entirety. The short f usion (200 ng /l) was coinjected with lin-15(ϩ) DNA (60 ng /l) into lin-15(n765ts) mutants, which have the multivulva (Muv) phenotype. NonMuv transgenic lines were established, GFP was visualized, and cell identities were determined using epifluorescence microscopy and Nomarski optics. The long f usion (100 ng /l) was linearized with SphI and coinjected with rol-6(d) DNA (100 ng /l) into wild-type animals. Rol transgenic lines were established, and serial images of L2 larvae were taken every 0.4 m with a deconvoluting microscope using epifluorescence. Figure 5e is a compressed image of the sum of 38 sections.
RESULTS

An egl-2 gain-of-function mutation causes multiple behavioral phenotypes
Two independently isolated dominant gain-of-function ( gf) mutations in the C. elegans egl-2 gene (n693 and n2656 ) inhibit egg-laying and enteric muscle contraction, leading to Egl and Exp phenotypes. These mutant phenotypes are rapidly rescued by exposure to tricyclic antidepressants such as imipramine, suggesting that the egl -2 gene product is a tricyclic target. Pharmacological and cell ablation manipulations combined with behavioral assays suggest that the Egl and Exp defects are likely in the egg-laying and enteric muscles and not in the motor neurons that innervate them (Reiner et al., 1995; Weinshenker et al., 1995) .
We tested egl-2 mutants for chemotaxis to volatile odorants, a behavior that is mediated by amphid sensory neurons. egl-2( gf) mutants were defective in chemotaxis to both isoamyl alcohol and benzaldehyde, which are sensed by the AWC amphid neuron (Bargmann et al., 1993) . Similar to the muscle defects, the isoamyl alcohol defect was rescued by imipramine ( Fig. 1) . Although egl-2( gf) has a weak locomotory defect, they were outperformed in this assay by the more severely locomotion-defective unc-25 mutant ( Fig. 1) , suggesting that the egl-2( gf) chemotaxis defect is caused by sensory and not motor defects.
egl-2( gf) mutants also had an imipramine-sensitive anterior mechanosensory-defective (Mec) phenotype, which is mediated by the AL M mechanosensory neurons (Chalfie and Sulston, 1981) (Table 1) . Previously characterized male mating and locomotion defects in egl-2( gf) mutant are likely neuronally mediated, and these are also rescued by imipramine (Trent et al., 1983; Weinshenker et al., 1995;  data not shown). These results demonstrate that an egl-2( gf) mutation can compromise neuronal and muscle f unction, and that its interaction with tricyclics is similar in the two tissues.
egl-2(gf) revertants define three classes of eag mutations
To determine the loss-of-f unction (lf ) phenotype for egl-2, we mutagenized egl-2( gf) animals and isolated revertants that were no longer Egl or E xp. All revertants were tightly linked to egl-2 (Materials and Methods), suggesting that they contain second site suppressors within the egl-2 gene.
To investigate the genetic properties of the revertants, we used the semidominance of the egl-2( gf) alleles in gene dosage tests. The enteric muscle contraction (EMC) defect of egl-2( gf) in trans to a deficiency of egl-2 is more severe than the gf in trans to a wild-type copy of egl-2 (Table 2) . A null mutation of egl-2 in trans to the gf would be expected to behave like a deficiency, whereas non-null mutations might give different results. We put each revertant in trans to egl-2( gf) and measured EMC defects ( Table  2 ). The revertants fell into three classes. Class I alleles (20 alleles), such as sa236, behaved like an egl-2 deficiency and probably are strong lf or null mutations. As homozygotes, egl-2(sa236 ) and other members of this class of revertants appear wild-type, having no gross defects in movement, feeding, fertility, defecation, egg laying, or chemotaxis to volatile odorants (Tables 1, 2 , Fig. 1 ; data not shown). Class II alleles (four alleles) behaved like a wild-type copy of egl-2. Class III alleles (eight alleles) suppressed the gf to a greater degree than a wild-type allele, and thus are probably dominant-negative alleles.
egl-2 encodes a voltage-gated K ؉ channel
To determine the role of egl-2 in cell excitation and the nature of the tricyclic antidepressant interaction, we cloned egl-2 (Materials and Methods). egl-2 encodes an eag-like voltage-gated K ϩ channel (VGK) (Fig. 2a) (GenBank accession number AF130443). The EGL-2 and Drosophila eag proteins are 54% identical in the N terminus, 75% identical in the transmembrane and pore domain, and 81% identical in the domain with homology to cyclic nucleotide-binding proteins (cNTP), but are divergent at the C terminus. The molecular lesion in the two independently isolated egl-2( gf) alleles is an A478V change in the S6 domain. This alanine is conserved among nearly all VGKs described to date, suggesting that this residue is critical for normal channel function (Fig. 2b) . The Class I sa236 mutation results in a stop codon at n904, n905, n906, sa236, sa371, sa372, sa373, sa374, sa381, sa383, sa384, sa386, sa388, sa389, sa390, sa392, sa393, sa394, sa396, and sa407. Class II alleles: n907, sa382, sa397, and sa399. C lass III alleles: sa375, sa377, sa378, sa380, sa385, sa387, sa391, and sa395 . Figure 2. Alignment of EGL -2 with other K ϩ channels. a, Predicted amino acid sequence of the egl-2 gene product and the molecular lesions found in mutant alleles aligned with Drosophila eag (EAG) and mouse eag (M EAG). The predicted transmembrane and pore domains are underlined, as is the region with homology to cyclic nucleotide-binding proteins (cN TP BI N DI NG DOM AI N). Amino acid identities are boxed in black. Amino acids changed in mutant egl-2 alleles are outlined in black and annotated on the line above. GFP f usion junctions are shown by vertical gray lines. b, Alignment of the sixth transmembrane domain (S6 ) of EGL -2 and other K ϩ channels. dEAG and dSHAK ER are Drosophila channels, UNC -103 is a C. elegans erg homolog, H ERG (human erg; mutated in long QT syndrome), K V L QT1 (mutated in long QT syndrome), and hSK1 (small conductance C a 2ϩ -activated K ϩ channel) are human channels, mSL O is a mouse large conductance C a 2ϩ -activated K ϩ channel, and AK T1 is an Arabidopsis inward-rectif ying K ϩ channel. The alanine that is mutated in egl-2(g f) alleles and the corresponding residues in other channels are boxed. GenBank accession numbers for sequences used: EGL -2 (AF130443), M EAG (UO4294), Drosophila EAG (M61157), Drosophila Shaker (M17211), UNC -103 (Z35596), H ERG (UO4270), K V L QT1 (U89364), hSK1 (AF131938), mSL O (L16912), and AK T1 (X62907). amino acid 84 (Fig. 2a) , and thus is probably a null allele. We identified molecular lesions for four C lass III dominant negative alleles. These lesions all cause single missense mutations affecting residues near S1 and S2: S213F (sa395), T230M (sa377 ), and T285I (sa378 and sa391) (Fig. 2a) .
S6 mutation shifts voltage dependence of activation for EGL-2 and murine MEAG channels
To investigate the mechanism underlying the in vivo phenotype of the egl-2( gf) mutations, we studied the properties of WT and gf mutant (A478V) EGL-2 channels expressed in Xenopus oocytes. Oocytes injected with wild-type egl-2 cRNA expressed voltagedependent, noninactivating potassium currents characterized by unusually slow activation kinetics, requiring voltage steps of 5 sec to approach steady-state (Fig. 3a) . A conductance-voltage ( G-V) plot of WT EGL-2 currents revealed a voltage of half-maximal activation (V 50 ) of Ϫ7 mV, centered within a voltage-operating range of ϳ80 mV (Fig. 3b) . Oocytes injected with mutant egl-2(A478V) cRNA expressed similar nonactivating potassium currents, but with altered voltage dependence of activation (Fig. 3a) . G-V plots for A478V EGL-2 channels revealed a V 50 of Ϫ40 mV, a shift of Ϫ33 mV relative to WT EGL-2 channels (Fig. 3b) . This hyperpolarized shift in the V 50 of A478V EGL-2 channels allows a significant fraction of available mutant channels to be activated Figure 3 . Functional properties of wildtype and gain-of-f unction EGL-2 and M EAG K ϩ channels in Xenopus oocytes assayed by two-electrode voltage-clamp. a, Current records from oocytes injected with wild-type egl-2, gain-of-function egl-2(A478V), and corresponding meag and meag(A492V) cRNAs. Currents evoked by families of voltage steps from a holding potential of Ϫ100 mV, in 10 mV increments [Ϫ90 to ϩ40 mV for egl-2 and egl-2(A478V)); Ϫ90 to ϩ50 mV for MEAG and M EAG(A492V)]. Outward tail currents observed from wild-type EGL-2 channels resulted from a repolarization step to Ϫ50 mV. A Ϫ100 mV repolarization step was used for all other channels. b, Normalized conductance-voltage relationships. Conductances were calculated from current amplitudes at the end of 5 sec [EGL -2 and EGL -2(A478V)] and 2 sec [M EAG and M EAG(A492V)] voltage steps, based on a reversal potential of Ϫ90 mV in N D96. Individual data sets were fitted by a single Boltzmann function,
Ϫ1 , where n is the slope factor reflecting intrinsic voltage sensitivity, V 50 is the voltage at half-maximal conductance, and T is absolute temperature. Mean values were plotted with SEM.
at hyperpolarized potentials. This is consistent with the observed mutant behavioral phenotypes of egl-2( gf) mutants, because a muscle or neuron expressing these mutant channels may be hyperpolarized and unable to respond appropriately to excitatory stimuli.
A478 is positioned near residues thought to undergo gatingdependent conformational changes in the Shaker potassium channel (Liu et al., 1997; Holmgren et al., 1998) . We therefore tested the ability of the A478V substitution to confer a gf phenotype in the murine eag homolog meag (Warmke and Ganetzky, 1994) , by engineering an analogous missense mutation in M EAG (A492V). A492V M EAG channels exhibited a G-V shifted toward hyperpolarized potentials (V 50 ϭ Ϫ13.7 mV) relative to W T MEAG (V 50 ϭ Ϫ3.4 mV) (Fig. 3a,b) , demonstrating a modest, but functionally similar effect of this substitution in a mouse eag-like channel
Imipramine blocks EGL-2 and MEAG channels
To determine the mechanism of imipramine rescue of the egl-2( gf) phenotypes, we assessed its ability to block EGL -2 channels in oocytes. Imipramine was able to block both W T and A478V EGL-2 channels (Fig. 4) . The derived Hill coefficients (s ϭ 0.84, WT; s ϭ 0.80, A478V) suggest a binding stoichiometry of one imipramine molecule to one channel. Similar results were obtained with W T M EAG channels (Fig. 4) , except that imipramine inhibits W T M EAG currents with an ϳ10-fold lower potency (K d ϭ 55 M) than EGL -2 currents.
Block by imipramine at each test concentration was rapid and essentially complete within the ϳ2 min allowed for equilibration between exchanges of bath solutions, at the holding potential of Ϫ100 mV. A variable secondary component of block was observed with much slower kinetics, perhaps reflecting state dependence of block (Kuo, 1998) . This secondary component of block may account for the residual 10% of channels not blocked with our assay conditions (Fig. 4) . Block was not observed to be reversible by washes of up to 30 min, consistent with a slow off-rate of imipramine. The rapid and dose-dependent inhibition of EGL-2 and MEAG channels provides evidence that imipramine directly blocks these channels and suggests that imipramine may block other EAG-like channels with similar efficacy.
EGL-2::GFP fusions are expressed in muscle and neurons
To determine the cellular expression pattern of egl-2, we constructed two EGL-2::GFP fusions (Materials and Methods; Fig.  2a) . Consistent with the Exp defect of egl-2( gf) mutants, the short fusion (4.1 kb of upstream egl-2 sequence) was expressed in the intestinal muscles, which are two of the four enteric muscles (Fig. 5a) . We hypothesize that inappropriately activated EGL-2 K ϩ channels in these muscles compromise their ability to depolarize and contract. In addition to the muscle expression, the short fusion was expressed in the AFD, ALN, AQR, ASE, AWC, BAG, IL2, PLN, PQR, and URX neurons in hermaphrodites and males, and in a subset of ray sensory neurons in males ( Fig. 5b; data not shown). The expression in AWC is consistent with the Figure 4 . Imipramine inhibits EGL -2 and M EAG channels. Doseresponse plots for wild-type EGL -2, EGL -2(A478V), and M EAG currents, measured at 40 mV, at the end of 5 sec [EGL -2 and EGL -2(A478V)] and 2 sec (MEAG) voltage steps from a holding potential of Ϫ100 mV. Individual data sets normalized to maximal current evoked in ND96 and fitted by the Hill f unction,
s )), where max is the maximal fractional inhibition, K d is the imipramine concentration at half-maximal inhibition, and s is the slope factor. Mean values were plotted with SEM. chemotaxis defect in egl-2( gf) mutants (Fig. 1) . Because ray neurons are involved in mating (Liu and Sternberg, 1995) , egl-2 expression in rays may underlie the previously characterized male mating defect of egl-2(g f) mutants (Trent et al., 1983) . The long f usion (5 kb of upstream egl-2 sequence, the entire 10 kb egl-2 coding region, and 4.2 kb of downstream egl-2 sequence) was highly localized at dendritic endings of neurons in the nose, but only faintly in the processes (Fig. 5e ). This localization is probably in the ciliated endings of head sensory neurons. Neuronal cell bodies in the lateral ganglion also label with this fusion (Fig. 5e ). This f usion was also expressed in the ALM mechanosensory neurons (Fig. 5c) , which can explain the egl-2( gf) anterior Mec phenotype (Table 1) . Consistent with the Egl defect of egl-2( gf) mutants, we saw occasional expression of this fusion in the vulval muscles used for egg laying (Fig. 5d) .
DISCUSSION
egl-2 encodes a voltage-gated K ϩ channel that is blocked by the tricyclic antidepressant imipramine. The egl-2( gf) mutation produces a negative shift in the voltage dependence of activation of EGL-2 channels, thus increasing the likelihood of open channels at hyperpolarized potentials. We propose that the egl-2( gf) phenotypes result from an inappropriate suppression of excitability in cells that express the mutant channel. Imipramine blocks the mutant channel and restores f unction by inhibiting the suppression of excitability. This model is supported by the close parallel between behavioral defects in egl-2( gf) mutants and EGL-2::GFP expression in cells that mediate these behaviors (Fig. 6 ).
egl-2(lf) phenotypes
We did not detect any gross behavioral defects in egl-2(lf ) mutants. We speculate that there are many K ϩ channels with overlapping f unctions in the excitable cells of C. elegans, and that loss of any one of them does not greatly affect cellular excitability. Conversely, activation of some of these channels causes an excitability phenotype out of proportion to their wild-type contribution. This generalization is supported by the severe phenotypes caused by gf mutations, in contrast to mild or absent phenotypes caused by lf mutations, in other C. elegans K ϩ channels (Reiner et al., 1995; Elkes et al., 1997; Johnstone et al., 1997) .
EGL-2 expression
The expression of the short EGL-2::GFP fusion in two of the four enteric muscles is consistent with the enteric muscle contraction defect of egl-2( gf) mutants. Vulval muscle labeling was observed in occasional animals expressing the long fusion, which can explain the Egl defect in egl-2( gf) mutants. This is consistent with the pharmacology of the egl-2( gf) Egl phenotype, as agonists that act directly on the egg-laying muscles to promote egg laying in the wild type fail to do so in egl-2( gf) mutants (Trent et al., 1983; Weinshenker et al., 1995) . Interestingly, nearly all neurons that express the fusions are sensory neurons, suggesting that egl-2 serves a common function in C. elegans sensory neurons of different modalities.
Like the long EGL-2::GFP fusion, components of the odorantsensing machinery are localized to the ciliated endings of amphid sensory neurons (Coburn and Bargmann, 1996; Sengupta et al., 1996; Colbert et al., 1997; Roayaie et al., 1998) . It is possible that EGL-2 functions in sensory endings and is modulated by components of sensory transduction. Drosophila eag mutants are defective in odorant response (Dubin et al., 1998) , and rat eag is expressed in the olfactory bulb (Ludwig et al., 1994) , suggesting conservation of an eag function in olfaction. In addition, bovine eag is expressed in retinal photoreceptors and may encode the native I K x current, suggesting a general role for eag in sensory transduction processes (Frings et al., 1998) .
K
؉ channel structure and function
Voltage-gated K ϩ channels display a remarkable heterogeneity of intrinsic properties, reflected in the molecular diversity of K ϩ channel genes (Wei et al., 1996) . The fact that the EGL-2 S6 alanine 478 is highly conserved among all families of VGKs Figure 6 . Summary of egl-2(gf) phenotypes, EGL -2 expression, and rescue by imipramine. Mutant EGL -2 channels are expressed in muscle and neurons and cause excitation defects by allowing an inappropriate efflux of K ϩ in these cells. Imipramine rescues egl-2(gf) phenotypes by blocking the mutant channels and restoring excitability.
suggests that it is critical for some aspect of normal channel function. This is supported by the gf shifts in G-V conferred by a modest change to a valine in EGL -2 and M EAG. Changing the analogous alanine in K V L QT1 channels to valine or glutamate results in the cardiac arrhythmia long QT syndrome, a probable dominant-negative phenotype (Wang et al., 1996; Shalaby et al., 1997) . These mutations focus attention on S6 as an important structure mediating channel f unction.
Examples of S6 amino acid substitution that either stabilize channel open states or accelerate transitions from closed to open states have been observed in a wide variety of other K ϩ channels. These include Shaw K ϩ channels (Elkes et al., 1997; Johnstone et al., 1997) , Slo-type calcium-activated K ϩ channels (Lagrutta et al., 1994) , the yeast YKC1 K ϩ channel (L oukin et al., 1997) , and the Shak er K ϩ channel (Liu et al., 1997; Holmgren et al., 1998) . Our data suggest that elements of the gating mechanism mediated by S6 may be conserved between K ϩ channels from diverse gene families. This suggestion is supported by the conserved "inverted teepee" structural motif revealed by the crystal structures of the Kcsa K ϩ channel from Streptomyces lividans (Doyle et al., 1998 ) and the MscL cation channel from Mycobacterium tuberculosis (Chang et al., 1998) . In both structures, the ion conduction pathway is lined by a single tilted transmembrane ␣-helix contributed by each subunit. This critical ␣-helix is TM2 for Kcsa, TM1 for MscL and, by analogy, S6 for voltage-gated K ϩ channel subunits. Rotation and translational movements of TM1 and TM2 underlie pH-dependent gating of the Kcsa channel (Perozo et al., 1999) and may provide a conserved structural mechanism used for gating in other potassium channels. Mutations of critical S6 residues could affect gating properties by influence the energetics of these conformational changes. Our data with egl-2 and meag are consistent this possibility.
The egl-2( gf) revertants may provide information about K ϩ channel structure and f unction. The C lass II revertants restore relatively normal f unction to the gf mutant channels. These are probably second site mutations that compensate for the gf mutation, and they potentially provide mechanistic information about channel gating. The C lass III alleles behave as dominant negatives. These mutations may suppress the gf mutation by directly or allosterically countering the action of A478V in S6. Alternatively, the suppressors could inhibit proper channel folding or processing independent of A478V. These alleles may provide a useful in vivo model for studying dominant-negative K ϩ channel subunit interactions.
Imipramine block of eag channels
We show that EGL -2 and M EAG channels are rapidly blocked by externally applied imipramine in a saturable fashion, with a high affinity in the range of 10 -100 M. These properties are in agreement with previous studies describing imipramine block of native K ϩ channels from cardiac myocytes (Isenberg and Tamargo, 1985) , peripheral sensory neurons (Ogata and Tatebayashi, 1993; Mathie, 1993, 1995) , and hippocampal neurons (Kuo, 1998) . Both noninactivating and transient native potassium currents are blocked by imipramine, depending on the tissue source. All reported native imipramine-sensitive currents tested have binding constants in the range of 10 -100 M and a putative external binding site. Our results suggest that these imipramine-sensitive currents may be encoded by K ϩ channel genes of the EAG gene family. Consistent with this possibility, heterologous expression studies reveal that the EAG gene family is capable of producing homomeric K ϩ channels with a diversity of kinetic properties, encompassing both noninactivating (eag, erg, elk subfamilies) and transient (erg, elk subfamilies) channel types (Shi et al., 1997 (Shi et al., , 1998 Engeland et al., 1998) . Among gf mutations in C. elegans that have been shown or hypothesized to activate K ϩ channels, egl-2( gf) is the only one that is rescued by imipramine (Reiner et al., 1995; Elkes et al., 1997; Johnstone et al., 1997) , suggesting a specific tricyclic-EAG interaction. The higher concentrations of imipramine required to rescue egl-2( gf) behavioral defects in vivo (ϳ25 M; E. Round, personal communication) than to block EGL-2 in vitro (ϳ10 M) is likely due to the general impermeability of the C. elegans cuticle (Lewis et al., 1980) . Should imipramine show specificity for K ϩ channels encoded by the EAG gene family, it may provide an attractive molecular substrate for the rational design of blocking agents that target members of this family (Mathie et al., 1998) .
EAG channels, tricyclic antidepressants, and human disease
The interaction between tricyclic antidepressants and EGL-2 provides a link that may explain one of the most common side effects of these psychotropic drugs. Long QT syndrome is a cardiac arrhythmia that can either be inherited or caused by drugs that block K ϩ channels (Tan et al., 1995) . One inherited form is associated with dominant-negative mutations in HERG, a VGK in the EAG gene family that encodes the cardiac I Kr K ϩ current (Sanguinetti et al., 1995; Trudeau et al., 1995) . Tricyclics can cause long QT syndrome, and we speculate that they may do so in part by blocking HERG channels. In support of this model, imipramine can significantly block I Kr currents in ventricular myocytes at concentrations found in the serum of patients taking clinical doses of the drug (ϳ1 M; Baldessarini, 1989; Valenzuela et al., 1994) . In addition, a human eag channel (h-eag) has recently been cloned, and both h-eag and rat eag channels are expressed in brain (Ludwig et al., 1994; Occhiodoro et al., 1998) . h-eag and meag are 100% conserved in the transmembrane and pore regions, indicating that imipramine probably blocks h-eag channels. Our results suggest that acute cardiac and neurological side effects of imipramine use may result from the block of HERG, h-eag, or other K ϩ channels encoded by the EAG gene family.
Putative targets of psychotropic drugs have been determined traditionally by assaying binding to known receptors in vitro. The combination of genetics and pharmacology in C. elegans offers an alternative means to identify and study these targets in vivo.
